Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
INVIVO THERAPEUTICS HOLDINGS CORP. | Chief Financial Officer | Stock Option (right to buy) | 20.8K | Nov 17, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
LEXX | Lexaria Bioscience Corp. | Aug 31, 2024 | 0 | $0 | 3 | Sep 5, 2024 | Chief Executive Officer |
NVIV | INVIVO THERAPEUTICS HOLDINGS CORP. | Nov 17, 2022 | 1 | $0 | 4 | Nov 21, 2022 | Chief Financial Officer |